The study of invariant light-chain β-2-microglobulin (β2M, required to maintain MHC I molecules conformation) transcripts in 166 BC samples obtained following resection from patients without previous chemotherapy and radiotherapy failed at establishing a link between BC molecular subtype or ER status and the expression of β2M messenger RNA (mRNA) [31]. The gene discussed is B2M; the disease is breast cancer.